Mechanisms and Barriers in Nanomedicine-2023
Mechanisms and Barriers in Nanomedicine-2023
批准号:
10683553
负责人:
THOMAS ANCHORDOQUY
金额:
$1.5万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-03-01 至 2024-02-29
关键词:
Artificial nanoparticlesAwardBiochemicalBiologicalBlood VesselsCategoriesCellular biologyClinicalClinical TrialsColoradoDisabled PersonsDisease modelDisparity populationDrug Delivery SystemsEducationEducational workshopEthnic PopulationEventFundingGoalsGrantImageImmuneImmunologicsImmunologyIndustrializationInternationalLearningMalignant NeoplasmsMinority GroupsModelingNanotechnologyPathologyPerformancePostdoctoral FellowPre-Clinical ModelProcessProteinsResearchResearch PersonnelRoleScientistSenior ScientistStudentsSystemSystems BiologyTranslationsTravelUnderrepresented PopulationsUpdateVisitWomancancer therapydesigndisadvantaged backgroundgraduate studentin vivoinnovationnanonanodrugnanomaterialsnanomedicinenanoparticle deliverynanotoxicitynovel strategiesparticleprogramsracial populationsenior facultysymposiumtranslational modeltumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In the recent years, remarkable progress has been made in the synthesis and characterization of
engineered nanoparticles for imaging and treatment of cancers, resulting in several promising
candidates in clinical trials. However, the nano drug delivery field needs a better understanding of
biological and immunological barriers, cancer pathology and immunology, and appropriate and relevant
models of disease. There is a growing sentiment in the field that there is need to revisit the basics and
to better understand the integrated biological, pathophysiological and immunological processes for
effective translation to nanomedicine design and performance. We propose to organize a conference-
workshop “Mechanisms and Barriers in Nanomedicine” in Golden, Colorado in May 2023. The program
will be focused on the following aspects: a) interactions at the particle interface; b) immune recognition
and toxicity of nanomaterials; c) relevance of models; d) in vivo barriers; d) new targets; d)
regulatory/industrial hurdles to translation. Leading experts will discuss the integrated roles of systems
immunology, protein corona, and tumor and vascular cell biology that modulate nanomedicine retention
and functionality in tumors. We strive to achieve the following goals: a) to provide an educational, yet
critical, forum into integrated biochemical and biological barriers controlling nanoparticle delivery and
their functionality; b) to present an update and potential paradigm shift on the strategies to mitigating
these problems; c) by conducting open, unrestricted, non-proprietary discussion among senior faculty,
young investigators and graduate students, we hope to trigger new ideas and concepts that will move
the field forward. The main innovation of the conference-workshop is in providing an open forum for
discussing problems with drug delivery and in the focus on biological, immunological and translational
aspects of nanotechnology. The R13 grant will be used to help with conference attendance for students
and postdocs, including underrepresented, racial and ethnic groups, individuals with disabilities,
individuals from disadvantaged backgrounds, and women.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exploiting an endogenous transcytotic pathway for oral drug delivery
-
批准号:9750224
-
项目类别:
-
资助金额:$49.88万
-
财政年份:2018
-
负责人:THOMAS ANCHORDOQUY
-
依托单位:
Exploiting an endogenous transcytotic pathway for oral drug delivery
-
批准号:9927660
-
项目类别:
-
资助金额:$47.23万
-
财政年份:2018
-
负责人:THOMAS ANCHORDOQUY
-
依托单位:
Tumor-Homing Exosomes for Drug Delivery
-
批准号:8579125
-
项目类别:
-
资助金额:$38.64万
-
财政年份:2013
-
负责人:THOMAS ANCHORDOQUY
-
依托单位:
Tumor-Homing Exosomes for Drug Delivery
-
批准号:8706865
-
项目类别:
-
资助金额:$37.6万
-
财政年份:2013
-
负责人:THOMAS ANCHORDOQUY
-
依托单位:
Tumor-Homing Exosomes for Drug Delivery
-
批准号:8900283
-
项目类别:
-
资助金额:$38.1万
-
财政年份:2013
-
负责人:THOMAS ANCHORDOQUY
-
依托单位:
Exploiting Cholesterol Nanodomains to Improve Targeting
-
批准号:8532683
-
项目类别:
-
资助金额:$27.81万
-
财政年份:2011
-
负责人:THOMAS ANCHORDOQUY
-
依托单位:
Exploiting Cholesterol Nanodomains to Improve Targeting
-
批准号:8332784
-
项目类别:
-
资助金额:$28.82万
-
财政年份:2011
-
负责人:THOMAS ANCHORDOQUY
-
依托单位:
Exploiting Cholesterol Nanodomains to Improve Targeting
-
批准号:8719128
-
项目类别:
-
资助金额:$28.57万
-
财政年份:2011
-
负责人:THOMAS ANCHORDOQUY
-
依托单位:
Exploiting Cholesterol Nanodomains to Improve Targeting
-
批准号:8040248
-
项目类别:
-
资助金额:$28.82万
-
财政年份:2011
-
负责人:THOMAS ANCHORDOQUY
-
依托单位:
Formulation of Synthetic Vectors as Lyophilized Products
-
批准号:7564799
-
项目类别:
-
资助金额:$23.44万
-
财政年份:2006
-
负责人:THOMAS ANCHORDOQUY
-
依托单位:
Formulation of Synthetic Vectors as Lyophilized Products
-
批准号:7095380
-
项目类别:
-
资助金额:$24.26万
-
财政年份:2006
-
负责人:THOMAS ANCHORDOQUY
-
依托单位:
Formulation of Synthetic Vectors as Lyophilized Products
-
批准号:7198128
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2006
-
负责人:THOMAS ANCHORDOQUY
-
依托单位:
Formulation of Synthetic Vectors as Lyophilized Products
-
批准号:7344767
-
项目类别:
-
资助金额:$23.44万
-
财政年份:2006
-
负责人:THOMAS ANCHORDOQUY
-
依托单位:
LYOPHILIZATION OF NONVIRAL GENE DELIVERY SYSTEMS
-
批准号:6351340
-
项目类别:
-
资助金额:$17.03万
-
财政年份:2000
-
负责人:THOMAS ANCHORDOQUY
-
依托单位:
LYOPHILIZATION OF NONVIRAL GENE DELIVERY SYSTEMS
-
批准号:6039012
-
项目类别:
-
资助金额:$18.17万
-
财政年份:2000
-
负责人:THOMAS ANCHORDOQUY
-
依托单位:
LYOPHILIZATION OF NONVIRAL GENE DELIVERY SYSTEMS
-
批准号:6498731
-
项目类别:
-
资助金额:$15.95万
-
财政年份:2000
-
负责人:THOMAS ANCHORDOQUY
-
依托单位:
海外基金